Nanobiotix: two appointments to the Supervisory Board

(CercleFinance.com) - Nanobiotix announces the appointments of Margaret A Liu and Anat Naschitz as censors to its Supervisory Board, subject to ratification by its shareholders at the next Annual General Meeting.


A global expert in vaccines, gene therapy and cancer immunotherapy, Margaret A Liu is Chief Executive Officer of PAX Therapeutics and a member of several boards, including that of Ipsen.

Anat Naschitz is a seasoned life sciences investor and entrepreneur, and co-founder of OrbiMed Israel. She is CEO of 9xchange, a drug discovery software platform using AI and machine learning.

Copyright (c) 2024 CercleFinance.com. All rights reserved.